Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion type Assertion NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_head.
- NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_provenance.
- NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion evidence source_evidence_literature NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_provenance.
- NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion SIO_000772 11692073 NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_provenance.
- NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion wasDerivedFrom befree-2016 NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_provenance.
- NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion wasGeneratedBy ECO_0000203 NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_provenance.